We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
  • Help
  1. Home
  2. News
  3. Politics
  4. 54 Bipartisan Members of Congress Urge Trump to Revive Cole Memo
  • News
  • Lifestyle
  • Strains & products
  • Industry
  • Growing
  • Health
  • Science & tech
  • Leafly USA
  • Podcasts
  • Learn
Politics

54 Bipartisan Members of Congress Urge Trump to Revive Cole Memo

Ben AdlinLast updated July 28, 2020
Sen. Elizabeth Warren, D-Mass., questions Alex Azar, left, President Donald Trump's nominee to become Secretary of Health and Human Services, during a Senate Health, Education, Labor and Pensions Committee confirmation hearing on Capitol Hill in Washington, Wednesday, Nov. 29, 2017. (AP Photo/Carolyn Kaster)

On the campaign trail, candidate Donald Trump said cannabis legalization should be left to the states. “In terms of marijuana and legalization, I think that should be a state issue, state-by-state,” he said in October 2015. “I really believe we should leave it up to the states.”

With the threat of a federal crackdown looming, a bipartisan group of congressional representatives is now urging the president to stand by his own words. “We trust you still hold this belief,” the group, led by Sen. Elizabeth Warren (D-MA) and Rep. Jared Polis (D-CO) wrote this week in letter to the White House.

It's the latest in a growing number of actions by members of Congress to defend and support state cannabis laws.

That letter, signed by 54 members of the US Senate and House and sent Thursday, calls on Trump to direct US Attorney General Jeff Sessions to reinstate the Cole memo, a Justice Department policy that urged prosecutors not to interfere in legal-cannabis states. Sessions rescinded the Obama-era memo earlier this month.

That rescission, wrote federal lawmakers, “puts jobs, small businesses, state infrastructure, consumers, minorities, and patients at risk. This action has the potential to unravel efforts to build sensible drug policies that encourage economic development as we are finally moving away from antiquated practices that have hurt disadvantaged communities.”

In place of the Cole memo, the attorney general’s new directive stresses that “marijuana activity is a serious crime” and leaves it to individual US attorneys to decide whether to bring charges in legal states. “This new guidance,” wrote the group of lawmakers, “will have a chilling effect across the country in states that have worked tirelessly to implement voter-approved laws, creating legal and economic uncertainty.”

The letter is the latest in a growing number of actions by members of Congress to defend and support state cannabis laws.

Federal Lawmakers Urge Trump to Revive Cole Memo by Ben Adlin on Scribd

Legal cannabis supports 149,304 American jobs in 2017 image
Industry
Legal cannabis supports 149,304 American jobs in 2017
Bruce Barcott and Gage Peake

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
cole memoCongressJeff Sessionslaw enforcementlaws
Ben Adlin
Ben Adlin
Ben Adlin is a Seattle-based writer and editor who specializes in cannabis politics and law. He was a news editor for Leafly from 2015-2019. Follow him on Twitter: @badlin
View Ben Adlin's articles

The latest in Politics

  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
  • Analysis: Don’t hold your breath for legalization under Trump 2.0 image
    Analysis: Don’t hold your breath for legalization under Trump 2.0
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.